| Completed | Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of C Pharmacokinetics | Phase 1 | 2016-07-01 |
| Terminated | Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Pr Breast Neoplasms | — | 2016-01-01 |
| Completed | Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study Healthy Subjects | Phase 1 | 2014-11-01 |
| Completed | First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending D Healthy Volunteers | Phase 1 | 2014-02-01 |
| Withdrawn | Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Ch Metastatic Melanoma | Phase 2 | 2014-01-01 |
| Completed | Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refra Multiple Myeloma | Phase 2 | 2013-12-01 |
| Terminated | Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia | Phase 1 | 2013-07-01 |
| Completed | 3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 Healthy Volunteers | Phase 1 | 2013-05-01 |
| Completed | Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Leukemia Lymphocytic Chronic B-Cell | Phase 1 | 2012-12-01 |
| Terminated | A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patient Colorectal Cancer | Phase 2 | 2009-12-01 |
| Completed | MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Rela Multiple Myeloma | Phase 1 / Phase 2 | 2008-06-01 |
| Terminated | Prevention of Restenosis Following Revascularization Vascular Disease, Peripheral | Phase 2 | 2008-01-01 |
| Unknown | A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells Hematologic Malignancies | — | 2007-05-01 |
| Terminated | A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Ly Diffuse Large B-cell Lymphoma | Phase 2 | 2007-05-01 |
| Completed | A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previousl Relapsed or Refractory Multiple Myeloma | Phase 3 | 2007-03-01 |
| Completed | A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. Newly Diagnosed Multiple Myeloma | Phase 3 | 2007-01-01 |
| Completed | A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Su Multiple Myeloma | Phase 3 | 2006-11-01 |
| Completed | Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Small Cell Lung Cancer | Phase 2 | 2006-04-01 |
| Terminated | Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safet Ovarian Cancer | Phase 1 / Phase 2 | 2005-11-01 |
| Terminated | Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia Myeloid Leukemia | Phase 1 | 2005-10-01 |
| Completed | Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multipl Multiple Myeloma | Phase 3 | 2005-09-01 |
| Terminated | Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety P Non-Small Cell Lung Cancer | Phase 1 | 2005-09-01 |
| Completed | Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma Non-Hodgkins Lymphoma | Phase 2 | 2005-08-01 |
| Completed | Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality Myelodysplastic Syndromes | Phase 3 | 2005-07-01 |
| Completed | Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis Coronary Restenosis | Phase 1 / Phase 2 | 2005-07-01 |
| Terminated | A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide Prostate Cancer | Phase 2 | 2005-04-01 |
| Completed | Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma Ovarian Cancer | Phase 1 / Phase 2 | 2005-04-01 |
| Terminated | A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcino Pancreatic Cancer | Phase 1 / Phase 2 | 2005-04-01 |
| Completed | A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2005-03-01 |
| Completed | Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Ca Breast Cancer | Phase 1 | 2005-03-01 |
| Terminated | Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome T Complex Regional Pain Syndrome, Type I | Phase 2 | 2005-02-01 |
| Completed | A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermedi Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS) | Phase 1 / Phase 2 | 2005-01-01 |
| Completed | Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy Radiculopathy | Phase 2 / Phase 3 | 2005-01-01 |
| Completed | Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas Glioblastoma, Malignant Gliomas | Phase 1 | 2003-12-01 |
| Completed | Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2003-12-01 |
| Completed | Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC) Prostate Cancer | Phase 2 | 2003-09-01 |
| Completed | A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS) Complex Regional Pain Syndrome (RSD) | Phase 2 | 2003-08-01 |
| Completed | Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes Myelodysplastic Syndromes | Phase 2 | 2003-06-01 |
| Completed | A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM) Multiple Myeloma | Phase 1 | 2003-03-01 |
| Completed | A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Un Multiple Myeloma | Phase 3 | 2003-02-01 |
| Completed | Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Me Melanoma, Neoplasm Metastasis | Phase 2 / Phase 3 | 2003-01-01 |
| Completed | D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patient Fatigue, Neoplasms | Phase 2 | 2002-06-01 |
| Terminated | A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Ch Colorectal Neoplasms, Diarrhea | Phase 2 | 2002-06-01 |
| Completed | A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple My Multiple Myeloma | Phase 2 | 2002-05-01 |
| Completed | A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease Crohn's Disease | Phase 2 | 2002-03-01 |
| Completed | A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplast Myelodysplastic Syndromes | Phase 3 | 2001-08-01 |
| Completed | Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer Breast Neoplasms, Metastases, Neoplasm | Phase 3 | 2001-06-01 |
| Completed | ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer Breast Neoplasms, Metastases, Neoplasm | Phase 2 | 2001-06-01 |
| Completed | A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies Neoplasms, Metastases, Neoplasm | Phase 1 | 2000-04-01 |
| Completed | A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in HIV Infections, HIV Wasting Syndrome | Phase 2 | — |
| Withdrawn | Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | — |
| Completed | Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome HIV Infections, HIV Wasting Syndrome | N/A | — |